Efficacy and safety of celecoxib monotherapy for mild to moderate depression in patients with colorectal cancer: A randomized double-blind, placebo controlled trial
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 255, 59-65
Abstract
No abstract availableKeywords
Funding Information
- Tehran University of Medical Sciences (28744)
This publication has 55 references indexed in Scilit:
- Does Chemotherapy Really Affect the Quality of Life of Women with Breast Cancer?Journal of Breast Cancer, 2013
- Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regressionJournal of Affective Disorders, 2012
- Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled TrialThe American Journal of Geriatric Psychiatry, 2012
- Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patientsInflammopharmacology, 2012
- Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional studyBMC Cancer, 2010
- Cancer-related inflammationNature, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- Standardization of the Korean Version of the Geriatric Depression Scale: Reliability, Validity, and Factor StructurePsychiatry Investigation, 2008
- Celecoxib for the Prevention of Colorectal Adenomatous PolypsNew England Journal of Medicine, 2006
- Assessment of Anxiety and Depression in Advanced Cancer Patients and their Relationship with Quality of LifeQuality of Life Research, 2005